In the light of the foregoing considerations, it is tempting to postulate that an elevation in circulating COMP levels in BA patients and those with advanced-stage might reflect compensatory mechanisms of the body that become activated in response to an imbalance in dynamic remodeling of ECM contributing to liver fibrosis. Here, COMP is linked to breast angiosarcoma.